Latest Options News

Regis Resources delivered a robust December quarter with 101.3koz gold production at $2,317/oz AISC, repaid $300 million debt early, and set a promising Exploration Target at Ben Hur.

Mandrake Resources has announced a significant maiden Inferred Resource of 3.3 million tonnes of Lithium Carbonate Equivalent at its Utah Lithium Project, alongside securing a US$1 million grant from the US Department of Energy to support further exploration and development.

Accelerate Resources Ltd has launched a new gold-focused strategy with the acquisition of a 70% interest in the Kanowna East Gold Project, located near major gold mines in Western Australia. The move positions the company to leverage significant historical gold intercepts and nearby processing infrastructure.

Titanium Sands Limited confirms that retention applications for its lapsed Orion Exploration Licences are approved in principle, with formal renewals pending amid Sri Lankan regulatory delays. The company remains confident in progressing its Mannar Island Project and securing necessary environmental and mining approvals.

Global X Management (AUS) Limited has announced estimated distribution amounts for its Australian-listed ETFs for the period ending January 31, 2025, providing clarity on upcoming income payments.

BPH Energy Limited's December 2024 quarterly report reveals strategic capital placements and investments in hydrogen and medical technology, alongside ongoing regulatory challenges with the PEP-11 permit.

Latin Resources Limited confirms the legal effectiveness of its acquisition by Pilbara Minerals Limited via share and option schemes, setting the stage for key trading milestones.

Olympio Metals has secured an option to acquire 80% of the promising Dufay Copper-Gold Project in Quebec and plans to commence drilling imminently, while divesting non-core assets to strengthen its balance sheet.

Saturn Metals reports strong assay results from its Apollo Hill Gold Project, reinforcing the deposit’s continuity and supporting its heap leach development strategy. An interim resource upgrade is imminent, with extensive drilling ongoing.

Australian Foundation Investment Company Limited (AFIC) has announced a fully franked dividend of AUD 0.12 per share for the half-year ending December 2024, accompanied by Dividend Reinvestment and Bonus Security Plans.

Australian Foundation Investment Company (AFIC) reported a 2.7% rise in half-year profit to $154.2 million and increased its interim dividend to 12 cents per share, while its portfolio outpaced the S&P/ASX 200 over the past year.

Island Pharmaceuticals has enrolled all subjects in the Phase 2b arm of its ISLA-101 dengue fever clinical trial, advancing its antiviral drug development with key results expected in 2025.